Equity Research
Fundamental analysis, company comparisons, balance-sheet reviews, and equity valuation.
Williams Companies Stock Analysis: Buy or Sell? Valuation & Leverage
Williams Companies (WMB) is rated Hold because its fee-based pipeline franchise is durable, but the stock already trades at a rich multiple. Negative free cash flow and 4.35x net debt/EBITDA keep the leverage risk front and center.
SM Energy Stock Analysis: Buy or Sell? Valuation, Leverage & FCF
SM Energy (SM) is a Buy, backed by $1.5B in trailing free cash flow and a 15.5% FCF yield. The stock looks undervalued at 5.1x EV/EBITDA, but leverage and tight liquidity remain the key risks.
FormFactor Stock Analysis: Buy or Sell? AI Demand, Customer Concentration & Valuation
FormFactor (FORM) is rated Hold as AI and HBM demand are driving strong growth, but the stock already discounts much of the upside. Rich valuation and customer concentration keep the risk-reward balanced.
NXP Semiconductors Stock Analysis: Buy or Sell? Valuation & Leverage
NXP Semiconductors (NXPI) is rated Hold as solid cash generation offsets a valuation that already prices in recovery. Free cash flow is strong, but 11B of debt and 1.3x net debt/EBITDA leave less room for a downturn.
Viking Therapeutics Stock Analysis: Buy or Sell? Cash Burn & Valuation
Viking Therapeutics (VKTX) is rated STRONG SELL because heavy cash burn is consuming a large cash balance while the stock still trades at a rich valuation. Phase 3 obesity progress remains the key swing factor, but the current risk/reward looks unfavorable.
Conagra Brands Stock Analysis: Buy or Sell? Valuation, Margin Repair & Leverage
Conagra Brands (CAG) is rated Hold as cash generation and a fair valuation offset weak earnings conversion and elevated leverage. The stock’s 6.3% free cash flow yield supports the case, but margin repair has not yet been durable enough to justify a Buy.
Power Solutions International Stock Analysis: Buy or Sell? Valuation & Free Cash Flow
Power Solutions International (PSIX) is rated Hold as cash generation and profitability support the business, but the recovery is still uneven. The stock looks fairly valued after a 20.5% TTM revenue decline, so tariff exposure and execution risk remain the key watchpoints.
AMN Healthcare Stock Analysis: Buy or Sell? Valuation, Cash Flow & Client Concentration
AMN Healthcare Services, Inc. (AMN) is rated Hold because cash generation is solid, but earnings remain uneven and the valuation is not cheap. Strong free cash flow supports the case, while Kaiser concentration and a demanding forward P/E keep the risk-reward balanced.
LifeStance Health Stock Analysis: Buy or Sell? Margins, Valuation & Growth
LifeStance Health Group, Inc. (LFST) is rated Hold as rapid revenue growth is offset by thin margins and a rich valuation. Payor concentration and only modest operating leverage remain the key items to watch.
Alignment Healthcare Stock Analysis: Buy or Sell? Margins, Valuation & Medicare Risk
Alignment Healthcare (ALHC) is rated Hold as fast revenue growth is offset by thin margins and Medicare Advantage exposure. The stock looks inexpensive on EV/revenue, but profitability remains too fragile for a stronger call.
Most Popular Research
Waitlist
Join the lf0 premium research waitlist.
More detailed equity research, scorecards, and performance analysis are coming. Add your email to be first in line.